Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas.
REWARDS
Trading at 67.3% below our estimate of its fair value
Earnings are forecast to grow 55.89% per year
RISK ANALYSIS
Interest payments are not well covered by earnings
Highly volatile share price over past 3 months
REWARDS
Trading at 67.3% below our estimate of its fair value
Earnings are forecast to grow 55.89% per year
RISK ANALYSIS
Interest payments are not well covered by earnings
Highly volatile share price over past 3 months
Lord MEDZ